A study to evaluate the effect of repeat oral doses of darapladib on cardiac conduction as compared to placebo and a single oral dose of moxifloxacin

Trial Profile

A study to evaluate the effect of repeat oral doses of darapladib on cardiac conduction as compared to placebo and a single oral dose of moxifloxacin

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2016

At a glance

  • Drugs Darapladib; Moxifloxacin
  • Indications Atherosclerosis; Diabetic macular oedema
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Sep 2007 Status changed from initiated to in progress.
    • 02 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top